Shares of Bristol Myers Squibb Co. BMY slumped 0.55% to $58.37 Wednesday, on what proved to be an all-around great trading ...

Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...

Bristol-Myers Squibb can probably continue to grow for a long time. Its dividend looks to be sustainable at the moment. But ...

Bristol Myers Squibb Co. closed $2.39 below its 52-week high ($61.08), which the company reached on November 11th.

Despite billions poured into research, new medicines still typically take a decade or more to develop.

BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...

Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out ...

We recently published a list of 10 Stocks That Are Close To Becoming Dividend Aristocrats. In this article, we are going to ...

The moves will affect more than 300 employees across both companies as both firms look to drive growth in the long term.

Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

LONDON (Reuters) - Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert ...